Antiandrogens and Androgen Inhibitors in Dermatologic Treatments

    November 2020 in “ Elsevier eBooks ”
    Najwa Somani, Marty E. Sawaya
    Studysummary This source outlines various antiandrogen and androgen inhibitor drugs used to treat cutaneous disorders of hyperandrogenism, detailing their mechanisms, uses, dosages, and side effects, with emphasis on spironolactone, finasteride, dutasteride, and oral contraceptives.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on linkinghub.elsevier.com →
    Discuss this study in the Community →

    Research cited in this study 72

    1. Is There a Role for Antiandrogen Therapy for Hidradenitis Suppurativa? A Systematic Review of Published Data American Journal of Clinical Dermatology · 2019
    2. North American Clinical Management Guidelines for Hidradenitis Suppurativa: A Publication from the United States and Canadian Hidradenitis Suppurativa Foundations Journal of the American Academy of Dermatology · 2019
    3. Efficacy of Topical Combination of 0.25% Finasteride and 3% Minoxidil Versus 3% Minoxidil Solution in Female Pattern Hair Loss: A Randomized, Double-Blind, Controlled Study American Journal of Clinical Dermatology · 2018
    4. A Randomized, Double-Blind Controlled Study of the Efficacy and Safety of Topical Solution of 0.25% Finasteride Admixed with 3% Minoxidil vs. 3% Minoxidil Solution in the Treatment of Male Androgenetic Alopecia Journal of The European Academy of Dermatology and Venereology · 2018
    5. Finasteride Topical Delivery Systems for Androgenetic Alopecia Current Drug Delivery · 2018
    6. Risk of Rhabdomyolysis from 5-Alpha Reductase Inhibitors Pharmacoepidemiology and Drug Safety · 2018
    7. Evidence-Based Guideline for the Treatment of Androgenetic Alopecia in Women and Men – Short Version Journal of The European Academy of Dermatology and Venereology · 2017
    8. Hidradenitis Suppurativa in Children Treated with Finasteride: A Case Series Pediatric Dermatology · 2017
    9. Frontal Fibrosing Alopecia: Clinical and Prognostic Classification JEADV. Journal of the European Academy of Dermatology and Venereology/Journal of the European Academy of Dermatology and Venereology · 2017
    10. Persistent Erectile Dysfunction in Men Exposed to 5α-Reductase Inhibitors, Finasteride, or Dutasteride PeerJ · 2017
    11. A Review of Hormone-Based Therapies to Treat Adult Acne Vulgaris in Women International Journal of Women's Dermatology · 2017
    12. Oral Spironolactone for Acne Vulgaris in Adult Females: A Hybrid Systematic Review American Journal of Clinical Dermatology · 2017
    13. Persistent Sexual Dysfunction with Finasteride 1 mg Taken for Hair Loss Pharmacotherapy · 2016
    14. Emotional Consequences of Finasteride: Fool’s Gold American Journal of Men's Health · 2016
    15. A Case Series of 20 Women with Hidradenitis Suppurativa Treated with Spironolactone Australasian Journal of Dermatology · 2015
    16. Effect of Dutasteride 0.5 mg/day in Men with Androgenetic Alopecia Recalcitrant to Finasteride International Journal of Dermatology · 2014
    17. Promotive Effect of Topical Ketoconazole, Minoxidil, and Minoxidil with Tretinoin on Hair Growth in Male Mice ISRN Pharmacology (Print) · 2014
    18. Frontal Fibrosing Alopecia: A Multicenter Review of 355 Patients Journal of The American Academy of Dermatology · 2014
    19. A Randomized, Active- and Placebo-Controlled Study of the Efficacy and Safety of Different Doses of Dutasteride Versus Placebo and Finasteride in the Treatment of Male Subjects with Androgenetic Alopecia Journal of The American Academy of Dermatology · 2014
    20. The Effectiveness of Finasteride and Dutasteride Used for 3 Years in Women with Androgenetic Alopecia Indian Journal of Dermatology, Venereology and Leprology · 2014
    21. Long-Term Oral Administration of 5α-Reductase Inhibitor Attenuates Erectile Function by Inhibiting Autophagy and Promoting Apoptosis of Smooth Muscle Cells in Corpus Cavernosum of Aged Rats Urology · 2013
    22. Neuroactive Steroid Levels Are Modified in Cerebrospinal Fluid and Plasma of Post-Finasteride Patients Showing Persistent Sexual Side Effects and Anxious/Depressive Symptomatology The Journal of Sexual Medicine · 2013
    23. Frontal Fibrosing Alopecia: A Retrospective Review of 19 Patients Seen at Duke University Journal of The American Academy of Dermatology · 2013
    24. Finasteride 5 mg/Day Treatment of Patterned Hair Loss in Normo-Androgenetic Postmenopausal Women International Journal of Trichology · 2013
    25. Comparative Effectiveness of Finasteride vs Serenoa Repens in Male Androgenetic Alopecia: A Two-Year Study International Journal of Immunopathology and Pharmacology · 2012
    26. Combination Therapy With Finasteride and Low-Dose Dutasteride in the Treatment of Androgenetic Alopecia Australasian Journal of Dermatology · 2012
    27. Hair Loss in Women: Medical and Cosmetic Approaches to Increase Scalp Hair Fullness British Journal of Dermatology · 2011
    28. Persistent Sexual Side Effects of Finasteride for Male Pattern Hair Loss The Journal of Sexual Medicine · 2011
    29. 5 mg/Day Finasteride Treatment for Normoandrogenic Asian Women with Female Pattern Hair Loss Journal of The European Academy of Dermatology and Venereology · 2010
    30. Efficacy, Safety, and Tolerability of Dutasteride 0.5 mg Once Daily in Male Patients with Male Pattern Hair Loss: A Randomized, Double-Blind, Placebo-Controlled, Phase III Study Journal of The American Academy of Dermatology · 2010
    31. Innovative Use of Spironolactone as an Antiandrogen in the Treatment of Female Pattern Hair Loss PubMed · 2010
    32. Finasteride Treatment for One Year in 35 Hirsute Patients Experimental and Clinical Endocrinology & Diabetes · 2009
    33. Spearmint Herbal Tea Has Significant Anti-Androgen Effects in Polycystic Ovarian Syndrome: A Randomized Controlled Trial PTR. Phytotherapy research/Phytotherapy research · 2009
    34. Treatment of Postmenopausal Frontal Fibrosing Alopecia with Oral Dutasteride Journal of The American Academy of Dermatology · 2009
    35. Medical Treatments for Male and Female Pattern Hair Loss Journal of The American Academy of Dermatology · 2008
    36. Antiandrogens for the Treatment of Hirsutism: A Systematic Review and Meta-Analyses of Randomized Controlled Trials ˜The œJournal of clinical endocrinology and metabolism/Journal of clinical endocrinology & metabolism · 2008
    37. The Importance of Dual 5α-Reductase Inhibition in the Treatment of Male Pattern Hair Loss: Results of a Randomized Placebo-Controlled Study of Dutasteride Versus Finasteride Journal of The American Academy of Dermatology · 2006
    38. Reversal of Androgenetic Alopecia by Topical Ketoconazole: Relevance of Anti-Androgenic Activity Journal of Dermatological Science · 2006
    39. Changes in Hair Weight in Men with Androgenetic Alopecia After Treatment with Finasteride (1 mg Daily): Three- and Four-Year Results Journal of The American Academy of Dermatology · 2006
    40. A New Look at the 5-Alpha-Reductase Inhibitor Finasteride Cns Drug Reviews · 2006
    41. Marked Suppression of Dihydrotestosterone in Men with Benign Prostatic Hyperplasia by Dutasteride, a Dual 5α-Reductase Inhibitor ˜The œJournal of clinical endocrinology and metabolism/Journal of clinical endocrinology & metabolism · 2004
    42. Progestogens With Antiandrogenic Properties Drugs · 2003
    43. Cutaneous Androgen Metabolism: Basic Research And Clinical Perspectives ˜The œjournal of investigative dermatology/Journal of investigative dermatology · 2002
    44. Hair Loss in Women with Hyperandrogenism: Four Cases Responding to Finasteride Journal of The American Academy of Dermatology · 2002
    45. Comparison of High-Dose Finasteride (5 mg/day) Versus Low-Dose Finasteride (2.5 mg/day) in the Treatment of Hirsutism European journal of endocrinology · 2002
    46. A Comparison of the Relative Efficacy of Antiandrogens for the Treatment of Acne in Hyperandrogenic Women Clinical Endocrinology · 2002
    47. Changes in Hair Weight and Hair Count in Men with Androgenetic Alopecia After Treatment with Finasteride, 1 mg, Daily Journal of The American Academy of Dermatology · 2002
    48. Lack of Efficacy of Finasteride in Postmenopausal Women with Androgenetic Alopecia Journal of The American Academy of Dermatology · 2000
    49. Androgenetic Alopecia: Treatments and Efficacy Dermatologic Clinics · 2000
    50. Improvement in Androgenetic Alopecia in 53-76-Year-Old Men Using Oral Finasteride International Journal of Dermatology · 1999
    51. Immunohistochemical Localization of Types 1 and 2 5α-Reductase in Human Scalp British Journal of Dermatology · 1999
    52. Finasteride in the Treatment of Men with Frontal Male Pattern Hair Loss Journal of The American Academy of Dermatology · 1999
    53. Effect of Finasteride in Idiopathic Hirsutism Journal of Endocrinological Investigation · 1998
    54. Finasteride in the Treatment of Men with Androgenetic Alopecia Journal of The American Academy of Dermatology · 1998
    55. Ketoconazole Shampoo: Effect of Long-Term Use in Androgenic Alopecia Dermatology · 1998
    56. Beneficial Effect of Spironolactone on Androgenic Alopecia Clinical Endocrinology · 1997
    57. Comparison of Finasteride Versus Spironolactone in the Treatment of Idiopathic Hirsutism Fertility and Sterility · 1997
    58. A Controlled Study of the Effects of RU58841, a Non-Steroidal Antiandrogen, on Human Hair Production by Balding Scalp Grafts Maintained on Testosterone-Conditioned Nude Mice British Journal of Dermatology · 1997
    59. Different Levels of 5α-Reductase Type I and II, Aromatase, and Androgen Receptor in Hair Follicles of Women and Men with Androgenetic Alopecia Journal of Investigative Dermatology · 1997
    60. Alopecia: The Search for Novel Agents Continues Expert Opinion on Therapeutic Patents · 1997
    61. Successful Treatment of Hirsutism in HAIR-AN Syndrome Using Flutamide, Spironolactone, and Birth Control Therapy Archives of dermatology · 1997
    62. Clinical Updates in Hair Dermatologic Clinics · 1997
    63. Outcome of Long-Term Treatment with the 5α-Reductase Inhibitor Finasteride in Idiopathic Hirsutism: Clinical and Hormonal Effects During a 1-Year Course of Therapy and 1-Year Follow-Up Fertility and Sterility · 1996
    64. Antiandrogen And Hormonal Treatment Of Acne Dermatologic Clinics · 1996
    65. Female Androgenetic Alopecia: An Update Australasian Journal of Dermatology · 1995
    66. The Role of Oral Contraceptives in the Treatment of Hyperandrogenic Disorders ˜The œAmerican journal of medicine · 1995
    67. Use of Spironolactone in the Treatment of Hirsutism Cleveland Clinic journal of medicine · 1990
    68. Spironolactone Is an Effective and Well-Tolerated Systemic Antiandrogen Therapy for Hirsute Women The Journal of Clinical Endocrinology & Metabolism · 1989
    69. Side Effects of Spironolactone Therapy in the Hirsute Woman ˜The œJournal of clinical endocrinology and metabolism/Journal of clinical endocrinology & metabolism · 1988
    70. Treatment of Female Androgenetic Alopecia With Cimetidine International Journal of Dermatology · 1987
    71. The Effect of Spironolactone on Hirsutism and Female Androgen Metabolism Clinical endocrinology · 1985
    72. The Effect of Spironolactone on Genital Skin 5α-Reductase Activity Journal of steroid biochemistry/Journal of Steroid Biochemistry · 1985